Clinical Trial Update: Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

A Phase 2 trial of azacitidine followed by GM-CSF in patients with myelodysplastic syndromes and leukemia was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Leukine (sargramostim)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2014-04-30